Briefcase Email Alerts Downloads Snapshot RSS Email Printed Materials Print this page


Press Releases

Press Releases
  Date Title and Summary View
Oct 19, 2004
Intellectual Property From Max Planck Society Strengthens Companies’ Leadership Positions In RNA-Based Drug Discovery and Development CAMBRIDGE, Mass., and CARLSBAD, Calif., Oct. 19 /PRNewswire-FirstCall/ — Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Isis Pharmaceuticals, Inc. ...
Page: FirstPrevious ...
= add release to Briefcase